ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia
Clinical Lymphoma Myeloma & Leukemia
◽
10.1016/j.clml.2019.10.018
◽
2020
◽
Vol 20
(4)
◽
pp. 226-233.e1
Author(s):
Benjamin K. Tomlinson
◽
Molly M. Gallogly
◽
Donna M. Kane
◽
Leland Metheny
◽
Hillard M. Lazarus
◽
...
Keyword(s):
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Wild Type
◽
Acute Myelogenous
◽
Unfit Patients
Download Full-text
Related Documents
Cited By
References
A Phase II Study of Sequential Decitabine and Rapamycin in Acute Myelogenous Leukemia
Leukemia Research
◽
10.1016/j.leukres.2021.106749
◽
2021
◽
pp. 106749
Author(s):
Jane L. Liesveld
◽
Andrea Baran
◽
Mitra Azadniv
◽
Haley Misch
◽
Katherine Nedrow
◽
...
Keyword(s):
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia
Cancer
◽
10.1002/1097-0142(19890301)63:5<813::aid-cncr2820630502>3.0.co;2-v
◽
1989
◽
Vol 63
(5)
◽
pp. 813-817
◽
Cited By ~ 36
Author(s):
Hagop M. Kantarjian
◽
Michael J. Keating
◽
Ronald S. Walters
◽
Charles A. Koller
◽
Kenneth B. McCredie
◽
...
Keyword(s):
Continuous Infusion
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Low Dose
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
A Phase II study of VNP40101M in elderly patients (pts) with de novo poor risk acute myelogenous leukemia (AML)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.7026
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 7026-7026
◽
Cited By ~ 2
Author(s):
G. J. Schiller
◽
D. DeAngelo
◽
N. Vey
◽
S. Solomon
◽
R. Stuart
◽
...
Keyword(s):
Elderly Patients
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
De Novo
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Poor Risk
◽
Acute Myelogenous
Download Full-text
Phase II study of VNP40101M in patients (pts) with acute myelogenous leukemia (AML) and high-risk myelodysplasia (MDS)
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.6541
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 6541-6541
◽
Cited By ~ 3
Author(s):
F. J. Giles
◽
S. O’Brien
◽
N. Vey
◽
E. Feldman
◽
D. Rizzieri
◽
...
Keyword(s):
High Risk
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
Phase II study of single agent clofarabine in previously untreated older adult patients with acute myelogenous leukemia (AML) unlikely to benefit from standard induction chemotherapy
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.7025
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 7025-7025
◽
Cited By ~ 5
Author(s):
H. P. Erba
◽
H. M. Kantarjian
◽
D. Claxton
◽
M. Arellano
◽
R. Lyons
◽
...
Keyword(s):
Older Adult
◽
Induction Chemotherapy
◽
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Single Agent
◽
Adult Patients
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia
Haematologica
◽
10.3324/haematol.2012.062539
◽
2012
◽
Vol 97
(11)
◽
pp. 1736-1742
◽
Cited By ~ 41
Author(s):
J. E. Karp
◽
E. Garrett-Mayer
◽
E. H. Estey
◽
M. A. Rudek
◽
B. D. Smith
◽
...
Keyword(s):
Phase Ii
◽
Cytosine Arabinoside
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Sequential Therapy
◽
Myelogenous Leukemia
◽
Newly Diagnosed
◽
Poor Risk
◽
Randomized Phase Ii
◽
Acute Myelogenous
Download Full-text
Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-13-1311
◽
2013
◽
Vol 20
(2)
◽
pp. 490-498
◽
Cited By ~ 74
Author(s):
Nitin Jain
◽
Emily Curran
◽
Neil M. Iyengar
◽
Ernesto Diaz-Flores
◽
Rangesh Kunnavakkam
◽
...
Keyword(s):
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Mek Inhibitor
◽
Myelogenous Leukemia
◽
University Of Chicago
◽
Acute Myelogenous
Download Full-text
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Cancer Discovery
◽
10.1158/2159-8290.cd-16-0313
◽
2016
◽
Vol 6
(10)
◽
pp. 1106-1117
◽
Cited By ~ 382
Author(s):
Marina Konopleva
◽
Daniel A. Pollyea
◽
Jalaja Potluri
◽
Brenda Chyla
◽
Leah Hogdal
◽
...
Keyword(s):
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
Salvage treatment for primary resistant acute myelogenous leukemia consisting of intermediate-dose cytosine arabinoside and interspaced continuous infusions of idarubicin: A phase-II study (no. 06901) of the EORTC Leukemia Cooperative Group
Annals of Hematology
◽
10.1007/s002770050148
◽
1996
◽
Vol 72
(3)
◽
pp. 119-124
◽
Cited By ~ 12
Author(s):
T. De Witte
◽
S. Suciu
◽
D. Selleslag
◽
B. Labar
◽
K. Roozendaal
◽
...
Keyword(s):
Phase Ii
◽
Cytosine Arabinoside
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Salvage Treatment
◽
Myelogenous Leukemia
◽
Cooperative Group
◽
Acute Myelogenous
◽
Intermediate Dose
Download Full-text
Faculty Opinions recommendation of Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726638619.793548558
◽
2018
◽
Author(s):
Stephen Nimer
Keyword(s):
Phase Ii
◽
Acute Myelogenous Leukemia
◽
Phase Ii Study
◽
Myelogenous Leukemia
◽
Acute Myelogenous
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close